Scandinavian Biopharma enters into Agreement with USAMRAA to facilitate the development of the oral vaccine ETVAX® against travellers’ diarrhoea
25th of September 2020, Scandinavian Biopharma (SBH) entered into an Agreement with the United States Army Medical Research Acquisition Activity (USAMRAA) to support the production and development of the vaccine, with the long-term goal of preventing bacterial diarrhoea in war fighters. In April this year, SBH announced the promising preliminary findings from a Phase 2b […]